Institute of Molecular Genetics of the Czech Academy of Sciences
Scientists from Institute of Molecular Genetics of the Czech Academy of Sciences identified new mechanisms of DNA repair in human cells. They found that RAD18 protein controls the choice of specific pathways used for repair of the DNA breaks and prevent development of genome instability that is one of the hallmarks of cancer. These new findings have recently been published in Nucleic Acids Research journal.
Genetic information encoded in the DNA is continuously damaged by various factors. Our cells protect themselves by efficiently repairing all lesions. Depending on the cell cycle phase, cells repair the breaks either by simply pasting both free ends of the rope together (so called NHEJ) or by a more complex process involving reconstruction of the damaged strand by copying an intact DNA template (so called homologous recombination).
The second process is much more precise but can act only when two copies of DNA are available. Mechanisms that govern selection of the correct DNA repair pathway are intensively studied as they represent potential targets for personalized cancer treatment.
We have now found that RAD18 recognizes specific epigenetic marks in the chromatin, promotes recruitment of several other proteins to the duplicated DNA and thus allows cells to repair DNA lesions through the error-free homologous recombination. “Using high resolution 3D-SIM microscopy, we observed RAD18 enrichment at the DNA breaks, and displacement of 53BP1 protein to the periphery, which suppressed inaccurate repair by ligation of DNA ends,” says the first author Matouš Palek.
Thanks to the support by Ministry of Health and National Institute of Cancer Research we established a collaboration with the CZECANCA consortium led by Prof. Zdenek Kleibl and identified several RAD18 mutations in Czech cancer patients.
Interestingly, some of these RAD18 mutations failed to promote DNA repair suggesting that they may contribute to genome instability which is an important driving force in cancer development. In the last decades, protein RAD18 has been implicated in cellular responses to UV light. We have now discovered a new layer of delicate regulation of DNA repair in human cells. “Contribution of the defects in RAD18 function to cancer and sensitivity to treatment will be a subject of our future research,” says Libor Macůrek, leader of the research team.
Matous Palek, Natalie Palkova, consortium CZECANCA, Petra Kleiblova, Zdenek Kleibl, Libor Macurek: RAD18 directs DNA double-strand break repair by homologous recombination to post-replicative chromatin. Nucleic Acids Res 2024. [doi]
